Psychosocial and Palliative Aspects of VAD Care

Martha Abshire Saylor; Shunichi Nakagawa

doi:10.1007/978-3-031-05713-7_18

Psychosocial and Palliative Aspects of VAD Care

Martha Abshire Saylor, Shunichi Nakagawa

School of Nursing

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Left ventricular assist devices (LVADs) have become the standard of care for end-stage heart failure refractory to medical therapy (Peura et al., Circulation (New York, NY) 126:2648–67, 2012). Studies have shown that LVADs improve survival as well as quality of life (Mehra et al., N Engl J Med 380:1618–27, 2019). LVAD technology has been advancing very rapidly and clinical outcomes continue to improve. However, the rate of complications with LVAD therapy remains high (Molina et al., Ann Thorac Surg 111:778–92, 2021), therefore, intense psychosocial evaluation prior to implant and support throughout therapy is warranted. This chapter will review the pre- and post-operative psychosocial considerations as well as discuss the end-of-life concerns that exist with device therapy.

Original language	English (US)
Title of host publication	A Guide to Mechanical Circulatory Support
Subtitle of host publication	A Primer for Ventricular Assist Device (VAD) Clinicians
Publisher	Springer International Publishing
Pages	243-253
Number of pages	11
ISBN (Electronic)	9783031057137
ISBN (Print)	9783031057120
DOIs	https://doi.org/10.1007/978-3-031-05713-7_18
State	Published - Jan 1 2022

Keywords

End of life
Ethics
Left ventricular assist device
Palliative
Psychosocial
Quality of life

ASJC Scopus subject areas

General Nursing
General Medicine

Access to Document

10.1007/978-3-031-05713-7_18

Cite this

@inbook{b2d4f8d17cdb49ee8c1bcbd93ff8664f,

title = "Psychosocial and Palliative Aspects of VAD Care",

abstract = "Left ventricular assist devices (LVADs) have become the standard of care for end-stage heart failure refractory to medical therapy (Peura et al., Circulation (New York, NY) 126:2648–67, 2012). Studies have shown that LVADs improve survival as well as quality of life (Mehra et al., N Engl J Med 380:1618–27, 2019). LVAD technology has been advancing very rapidly and clinical outcomes continue to improve. However, the rate of complications with LVAD therapy remains high (Molina et al., Ann Thorac Surg 111:778–92, 2021), therefore, intense psychosocial evaluation prior to implant and support throughout therapy is warranted. This chapter will review the pre- and post-operative psychosocial considerations as well as discuss the end-of-life concerns that exist with device therapy.",

keywords = "End of life, Ethics, Left ventricular assist device, Palliative, Psychosocial, Quality of life",

author = "Saylor, {Martha Abshire} and Shunichi Nakagawa",

note = "Publisher Copyright: {\textcopyright} The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2022, corrected publication 2023.",

year = "2022",

month = jan,

day = "1",

doi = "10.1007/978-3-031-05713-7_18",

language = "English (US)",

isbn = "9783031057120",

pages = "243--253",

booktitle = "A Guide to Mechanical Circulatory Support",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Psychosocial and Palliative Aspects of VAD Care

AU - Saylor, Martha Abshire

AU - Nakagawa, Shunichi

N1 - Publisher Copyright: © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2022, corrected publication 2023.

PY - 2022/1/1

Y1 - 2022/1/1

N2 - Left ventricular assist devices (LVADs) have become the standard of care for end-stage heart failure refractory to medical therapy (Peura et al., Circulation (New York, NY) 126:2648–67, 2012). Studies have shown that LVADs improve survival as well as quality of life (Mehra et al., N Engl J Med 380:1618–27, 2019). LVAD technology has been advancing very rapidly and clinical outcomes continue to improve. However, the rate of complications with LVAD therapy remains high (Molina et al., Ann Thorac Surg 111:778–92, 2021), therefore, intense psychosocial evaluation prior to implant and support throughout therapy is warranted. This chapter will review the pre- and post-operative psychosocial considerations as well as discuss the end-of-life concerns that exist with device therapy.

AB - Left ventricular assist devices (LVADs) have become the standard of care for end-stage heart failure refractory to medical therapy (Peura et al., Circulation (New York, NY) 126:2648–67, 2012). Studies have shown that LVADs improve survival as well as quality of life (Mehra et al., N Engl J Med 380:1618–27, 2019). LVAD technology has been advancing very rapidly and clinical outcomes continue to improve. However, the rate of complications with LVAD therapy remains high (Molina et al., Ann Thorac Surg 111:778–92, 2021), therefore, intense psychosocial evaluation prior to implant and support throughout therapy is warranted. This chapter will review the pre- and post-operative psychosocial considerations as well as discuss the end-of-life concerns that exist with device therapy.

KW - End of life

KW - Ethics

KW - Left ventricular assist device

KW - Palliative

KW - Psychosocial

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=85164851572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85164851572&partnerID=8YFLogxK

U2 - 10.1007/978-3-031-05713-7_18

DO - 10.1007/978-3-031-05713-7_18

M3 - Chapter

AN - SCOPUS:85164851572

SN - 9783031057120

SP - 243

EP - 253

BT - A Guide to Mechanical Circulatory Support

PB - Springer International Publishing

ER -

Psychosocial and Palliative Aspects of VAD Care

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this